As of 2025-11-09, the Intrinsic Value of Anavex Life Sciences Corp (AVXL) is -2.80 USD. This Anavex valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.29 USD, the upside of Anavex Life Sciences Corp is -138.47%.
Based on its market price of 7.29 USD and our intrinsic valuation, Anavex Life Sciences Corp (AVXL) is overvalued by 138.47%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.80 - -2.80 | -2.80 | -138.47% |
| P/E | (8.58) - (8.58) | (8.58) | -217.7% |
| DDM - Stable | (3.29) - (9.01) | (6.15) | -184.4% |
| DDM - Multi | (0.88) - (1.90) | (1.20) | -116.5% |
| Market Cap (mil) | 626.14 |
| Beta | 1.46 |
| Outstanding shares (mil) | 85.89 |
| Enterprise Value (mil) | 524.97 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.76% |
| Cost of Debt | 5.00% |
| WACC | 8.87% |